Autologous fecal microbiota transplantation: Ph Ib ongoing

An independent DSMB recommended continuation of the open-label, French Phase Ib ODYSSEE trial evaluating autologous fecal microbiota transplantation in about 35 patients with acute myelogenous leukemi...